Infection, inflammation, and cerebrovascular ischemia

Neurology

Volumn 49, Issue 5 SUPPL., 1997, Pages

  Grau, Armin J ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFECTION RISK; INFLAMMATION; MALE; PATHOGENESIS; PREDICTION; PRIORITY JOURNAL; RISK FACTOR;

EID: 0030680099     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.49.5_suppl_4.s47     Document Type: Article

References (33)

1. Ernst E, Hammerschmidt DE, Bagge U, Matrai A, Dormandy JA. Leukocytes and the risk of ischemic diseases. JAMA 1987; 257:2318-2323.
2. Kannel WB, Anderson K, Wilson PWF. White blood cell count and cardiovascular disease. Insights from the Framingham Study. JAMA 1992;267:1253-1256.
3. Olivares R, Ducimetiére P, Claude JR. Monocyte count: a risk factor for coronary heart disease. Am J Epidemiol 1993;137: 49-53.
4. Ernst E, Resch KL: Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Ann Intern Med 1993;118:956-963.
5. Mori T, Sasaki J, Kawaguchi K, et al. Serum glycoproteins and severity of coronary atherosclerosis. Am Heart J 1995; 129:234-238.
6. Grau A, Buggle F, Heindl S, et al. Recent infection as a risk factor for cerebrovascular ischemia. Stroke 1995;26:373-379.
7. Grau A, Buggle F, Steichen-Wiehn C, et al. Clinical and biochemical analysis in infection-associated stroke. Stroke 1995; 26:1520-1526.
8. Grau A, Buggle F, Becher H, Werle H, Hacke W. The association of leukocyte count, fibrinogen and C-reactive protein with vascular risk factors and ischemic vascular diseases. Thromb Res 1996;82:245-255.
9. Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC: C-reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ 1996;312: 1061-1065.
10. Lee AJ, Lowe GDO, Woodward M, Tunstall-Pedoe H. Fibrinogen in relation to personal history of prevalent hypertension, diabetes, stroke, intermittent claudication, coronary heart disease, and family history: the Scottish Heart Health Study. Br Heart J 1993;69:338-342.
11. Kannel WB. Metabolic risk factors for coronary heart disease in women: perspective from the Framingham Study. Am Heart J 1987;147:413-419.
12. Grau A, Seitz R, Immel A, Steichen-Wiehn C, Hacke W. Increased levels of leukocyte elastase in ischemic stroke and in subjects with vascular risk factors. Cerebrovasc Dis 1995;5: 50-54.
13. Anachenko VG, Vakolyuk RM, Kuznetsov SV, Malashenkova IK, Streitsova TV, Strizhova NV. The NBT test in hypertensive patients. Sovietskaia Meditsina 1986;10:3-5.
14. Stuart J, George AJ, Davies AJ, Aukland A, Hurlow RA. Haematological stress syndrome in atherosclerosis. J Clin Pathol 1981;34:464-467.
15. Munro JM, Cotran RS. The pathogenesis of atherosclerosis: atherogenesis and inflammation. Lab Invest 1988;58:249-261.
16. Sirén AL, Heldman E, Doron D, et al. Release of proinflammatory and prothrombotic mediators in the brain and peripheral circulation in spontaneously hypertensive and normotensive Wistar-Kyoto rats. Stroke 1992;23:1643-1651.
17. Hallenbeck JM, Dutka AJ, Kochanek PM, Sirén A, Pezeshkpour GH, Feuerstein G. Stroke risk factors prepare rat brain-stem tissues for modified local Shwartzman reaction. Stroke 1988;19:863-869.
18. Mattila KJ, Nieminen MS, Valtonen VV. Association between dental health and acute myocardial infarction. BMJ 1995;311: 711-714.
19. Syrjänen J, Peltola J, Valtonen V, Iivanainen M, Kaste M, Huttunen JK. Dental infections in association with cerebral infarction in young and middleaged men. J Intern Med 1989; 225:179-184.
20. Jousilahti P, Vartiainen E, Tuomilehto J, Puska P. Symptoms of chronic bronchitis and the risk of coronary disease. Lancet 1996;348:567-572.
21. Patel P, Mendall MA, Carrington D, et al. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. BMJ 1995;311:711-714.
22. Wimmer M, Sandmann-Strupp R, Saikku P, Haberl RL. Association of chlamydial infection with cerebrovascular disease. Stroke 1996;27:2207-2210.
23. Grayston JT. Chlamydia in atherosclerosis. Editorial comment. Circulation 1993;87:1408-1409.
24. Nieto FJ, Adam E, Sorlie P, et al. Cohort study of Cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis. Circulation 1996;94:922-927.
25. Syrjänen J, Valtonen VV, Iivanainen M, Kaste M, Huttunen JK. Preceding infection as an important risk factor for ischaemic brain infarction in young and middle aged patients. BMJ 1988:296:1156-1160.
26. Hesselvik JF, Malm J, Dahlbäck B, Blombäck. Protein C, protein S and C4b-binding protein in severe infection and septic shock. Thromb Haemost 1991;65:126-129.
27. Esmon CT, Taylor FB, Snow TR. Inflammation and coagulation: linked processes potentially regulated through a common pathway mediated by protein C. Thromb Haemost 1991;66: 160-165.
28. Schleef RR, Bevilacqua MP, Sawdey M, Gimbrone MA, Loskutoff DJ. Cytokine activation of vascular endothelium. J Biol Chem 1988;263:5797-5803.
29. Van der Poll T, Büller HR, ten Gate H, et al. Activation of coagulation after administration of tumor necrosis factor to normal subjects. N Engl J Med 1990;322:1622-1627.
30. Rivers RPA, Hathaway WE, Weston WL. The endotoxin-induced coagulant activity of human monocytes. Br J Haematol 1975;30:311-316.
31. Ameriso SF, Wong VLY, Quismorio FP Jr, Fisher M. Immunohematologic characteristics of infection-associated cerebral infarction. Stroke 1991;22:1004-1009.
32. Cermak J, Key NS, Bach RR, Balla J, Jacob HS, Vercellotti GM. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 1993;82:513-520.
33. Galve-de Rochemonteix B, Wiktorowicz K, Kushner I, Dayer JM. C-reactive protein increases production of IL-1a, IL-1b, and TNF-a, and expression of mRNA by human alveolar macrophages. J Leukocyte Biol 1993;53:439-445.